John A. Farmer

5.9k total citations · 1 hit paper
105 papers, 3.8k citations indexed

About

John A. Farmer is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John A. Farmer has authored 105 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Surgery, 35 papers in Cardiology and Cardiovascular Medicine and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John A. Farmer's work include Lipoproteins and Cardiovascular Health (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Blood Pressure and Hypertension Studies (10 papers). John A. Farmer is often cited by papers focused on Lipoproteins and Cardiovascular Health (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Blood Pressure and Hypertension Studies (10 papers). John A. Farmer collaborates with scholars based in United States, United Kingdom and Germany. John A. Farmer's co-authors include Antonio M. Gotto, Guillermo Torre‐Amione, John R. Guyton, J A Kautz, Sina Attar Roshan, G. Dahlén, Christie M. Ballantyne, Peter H. Jones, J. Alan Herd and James B. Young and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

John A. Farmer

99 papers receiving 3.6k citations

Hit Papers

Association of levels of lipoprotein Lp(a), plasma lipids... 1986 2026 1999 2012 1986 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Farmer United States 31 2.2k 1.1k 882 523 467 105 3.8k
Evan A. Stein United States 27 2.6k 1.2× 818 0.7× 1.7k 1.9× 616 1.2× 400 0.9× 59 4.7k
Yuan‐Lin Guo China 29 1.8k 0.8× 1.2k 1.1× 994 1.1× 428 0.8× 322 0.7× 156 3.2k
Hanna Mäenpää Finland 22 2.0k 0.9× 746 0.7× 1.7k 2.0× 825 1.6× 945 2.0× 54 4.8k
Gabriele Riccardi Italy 14 3.0k 1.4× 1.5k 1.3× 1.6k 1.8× 583 1.1× 306 0.7× 20 4.5k
Steven Joyal United States 9 2.9k 1.3× 1.2k 1.1× 1.2k 1.3× 466 0.9× 340 0.7× 15 4.0k
A Notarbartoló Italy 34 2.2k 1.0× 999 0.9× 969 1.1× 325 0.6× 292 0.6× 152 4.3k
Olivier Descamps Belgium 28 2.9k 1.3× 1.1k 1.0× 1.5k 1.7× 841 1.6× 492 1.1× 86 4.5k
Leslie Lipka United States 24 2.4k 1.1× 1.0k 0.9× 762 0.9× 902 1.7× 303 0.6× 44 3.7k
David A. DeMicco United States 33 2.6k 1.2× 1.5k 1.3× 1.8k 2.1× 534 1.0× 311 0.7× 69 4.5k
James H. Revkin United States 18 3.2k 1.5× 1.2k 1.1× 2.3k 2.6× 879 1.7× 572 1.2× 39 4.8k

Countries citing papers authored by John A. Farmer

Since Specialization
Citations

This map shows the geographic impact of John A. Farmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Farmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Farmer more than expected).

Fields of papers citing papers by John A. Farmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Farmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Farmer. The network helps show where John A. Farmer may publish in the future.

Co-authorship network of co-authors of John A. Farmer

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Farmer. A scholar is included among the top collaborators of John A. Farmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Farmer. John A. Farmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farmer, John A.. (2013). The Effect of Statins on Skeletal Muscle Function: The STOMP Trial. Current Atherosclerosis Reports. 15(8). 347–347. 6 indexed citations
2.
Ram, C. Venkata S. & John A. Farmer. (2012). Metabolic Syndrome in South Asians. Journal of Clinical Hypertension. 14(8). 561–565. 16 indexed citations
3.
Farmer, John A., et al.. (2010). Dysfunctional High-Density Lipoprotein and Atherosclerosis. Current Atherosclerosis Reports. 12(5). 343–348. 50 indexed citations
4.
Farmer, John A.. (2010). Effect of Extended-Release Niacin or Ezetimibe on Carotid Intimal Thickness: The ARBITER-HALTS Study. Current Atherosclerosis Reports. 12(5). 285–287. 2 indexed citations
5.
Farmer, John A.. (2008). Clinical trials and surrogate end points:lessons from the ENHANCE trial. 3(4). 353–357. 1 indexed citations
6.
Gotto, Antonio M. & John A. Farmer. (2006). Drug Insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nature Clinical Practice Cardiovascular Medicine. 3(12). 664–672. 18 indexed citations
7.
Manhas, Amit & John A. Farmer. (2004). Hypolipidemic therapy and cholesterol absorption. Current Atherosclerosis Reports. 6(2). 89–93. 16 indexed citations
8.
Farmer, John A., et al.. (2003). Novos fatores de risco cardiovascular. 183–193. 3 indexed citations
9.
Farmer, John A.. (2003). The Spector of Crypto-anarchy: Regulating Anonymity-Protecting Peer-To-Peer Networks. Fordham law review. 72(3). 725. 6 indexed citations
10.
Stetson, Sonny J., et al.. (2002). The role of inflammation in the pathogenesis of heart failure. Current Cardiology Reports. 4(3). 200–205. 14 indexed citations
11.
Farmer, John A. & Antonio M. Gotto. (2002). Dyslipidemia and the vulnerable plaque. Progress in Cardiovascular Diseases. 44(6). 415–428. 25 indexed citations
12.
Lakkis, Nasser, et al.. (2002). Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisited. Catheterization and Cardiovascular Interventions. 56(4). 474–477. 18 indexed citations
13.
Farmer, John A.. (2001). Learning from the cerivastatin experience. The Lancet. 358(9291). 1383–1385. 80 indexed citations
14.
Farmer, John A.. (2000). Pleiotropic effects of statins. Current Atherosclerosis Reports. 2(3). 208–217. 123 indexed citations
15.
Torre‐Amione, Guillermo, et al.. (1999). Clinical implications of tumour necrosis factor α antagonism in patients with congestive heart failure. Annals of the Rheumatic Diseases. 58. I103–I106. 6 indexed citations
16.
Ballantyne, Christie M., J. Alan Herd, Jeffrey Schein, et al.. (1998). Treatment of patients with mild to moderate hypercholesterolemia: Lipoprotein and Coronary Atherosclerosis Study (LCAS). 19(1). 12–24. 2 indexed citations
17.
Dakik, Habib A., Neal S. Kleiman, John A. Farmer, et al.. (1998). Intensive Medical Therapy Versus Coronary Angioplasty for Suppression of Myocardial Ischemia in Survivors of Acute Myocardial Infarction. Circulation. 98(19). 2017–2023. 83 indexed citations
18.
Farmer, John A. & Antonio M. Gotto. (1994). Antihyperlipidaemic Agents. Drug Safety. 11(5). 301–309. 23 indexed citations
19.
Smart, Frank W., Christie M. Ballantyne, John A. Farmer, et al.. (1991). Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. The American Journal of Cardiology. 67(4). 243–247. 162 indexed citations
20.
Byrd, William, et al.. (1990). A portrait of The Cambridge Singers. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026